52.7
Theriva Biologics, Inc.
Metrics score locked — part of Premium
FY22
FY22
FY23
FY24
FY25
FY22 – FY25
Assets
(positive)
Change from FY22 to FY25
millions USD
FY22:
FY22:
45.5
FY23:
27.4
FY24:
16.3
FY25:
17.5
(positive)
Change from FY22 to FY25
millions USD
FY22:
24.4
FY22:
26.3
FY23:
27.8
FY24:
19.1
FY25:
20.8
Total assets
Change from FY22 to FY25
millions USD
FY22:
77.1
FY22:
71.9
FY23:
55.2
FY24:
35.4
FY25:
38.2
Liabilities & Equity
(negative)
Change from FY22 to FY25
millions USD
FY22:
12.3
FY22:
7.06
FY23:
6.74
FY24:
7.59
FY25:
10.0
(negative)
Change from FY22 to FY25
millions USD
FY22:
5.67
FY22:
10.2
FY23:
8.78
FY24:
8.70
FY25:
12.8
(positive)
Change from FY22 to FY25
millions USD
FY22:
56.4
FY22:
51.8
FY23:
37.0
FY24:
19.1
FY25:
15.4
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY22:
–
FY22:
–
FY23:
–
FY24:
35.4
FY25:
38.2
All amounts in millions USD